THORACIC AND CARDIOVASC SURGE

Size: px
Start display at page:

Download "THORACIC AND CARDIOVASC SURGE"

Transcription

1 Volume 95, Number 5 The Jqurnal of THORACIC AND CARDIOVASC SURGE Official organ The American Association for Thor The Western Thoracic Surgical Association Editor JOHN W. KIRKLIN, Birmingham, Ala. Associate editor EUGENE H. BLACKSTONE, Birmingham, Ala. THE AMERICAN ASSOCIATION FOR THORACIC SURGERY Next Meeting, May 8-1, 1989 Headquarters, Sheraton HoteljHynes Convention Center, Boston, Massachusetts (See page 943) THE WESTERN THORACIC SURGICAL ASSOCIATION Next Meeting, June 22-25, 1988 Headquarters, Sheraton Royal Waikoloa Hotel, Hawaii (For Program see page 947) Published by The C V. Mosby Company St. Louis, Mo. ISSN University of Michigan Exhibit 23 St. Jude Medical v. University of Michigan IPR

2 Exh. 23 Page 1 Volume 95, Number 5 The Jqurnal of THORACIC AND CARDIOVASC SURGE Official organ The American Association for Thor The Western Thoracic Surgical Association Editor JOHN W. KIRKLIN, Birmingham, Ala. Associate editor EUGENE H. BLACKSTONE, Birmingham, Ala. THE AMERICAN ASSOCIATION FOR THORACIC SURGERY Next Meeting, May 8-1, 1989 Headquarters, Sheraton HoteljHynes Convention Center, Boston, Massachusetts (See page 943) THE WESTERN THORACIC SURGICAL ASSOCIATION Next Meeting, June 22-25, 1988 Headquarters, Sheraton Royal Waikoloa Hotel, Hawaii (For Program see page 947) Published by The C V. Mosby Company St. Louis, Mo. ISSN

3 Exh. 23 Page 2 1 THORAC CARDIOYASC SuRa 1988;95:912-9 Hemodynamic and pathologic evaluation of a unileaflet pericardia! bioprosthetic valve This study investigate<i the in vivo hemodynamics and pathologic changes. of a unileaflet pericardia( bioprosthetic valve 3 to 5 months after implantation in juvenile sheep. Group 1 had 1 sheep with tricuspid valve replacement. 2 had nine sheep with mitral valve replacement. Group 3 served as a control with 1 sheep that had valve replacement with a trileaftet. porcine bioprosthesis. Hemodynamic performance was satisfactory in all three groups despite prominent. pathologic changes, particularly in unileaftet valves. Intrinsic cuspal calcification was present il_l 66% of the unileaftet tricuspid, 88 % unileaftet mitral, and 25 % porcine tricuspid valves. Neither cuspal tearing nor perforations were However, cuspal stretching and redundancy of the mobile cusp was present in six tricuspid, seven mitral unileaftet valves, and. no porcine valves. Gross pericardial redundancy correlated with the microscopic appearance of distorted and separated. collagen bundles. These findings suggest that multiple modes of primary tissue failure may limit the durability of this unileaftet pericardia} valve. Richard J. Shemin, MD, Frederick J. Schoen, MD, PhD, Robert Hein, MD, John Austin, MD, and Lawrence H. Cohn, MD, Boston, Mass. Bioprostheses have advantages over mechanical prostheses including a near-physiologic central flow orifice and superior thromboresistance, usually without longterm anticoagulation. 1-3 Nevertheless, clinically used bioprostheses fabricated from either porcine aortic valve or bovine pericardium fail frequently, often through degenerative processes, most prominently mineralization, which cuspal stiffening or tearing, or both.4-1 Attempts to enhance durability have included improved procurement techniques, low-pressure glutaraldehyde fixation, calcification-retarding substances,. and careful intraoperative handling Recently, new structural designs have appeared that present a of theoretical he!jlodynamic advantages, especially in small annular sizes. The novel unileaflet pericardia! bioprosthesis, developed by Meadox Medicals, Inc. (Oakland, N.1.) has a single leaflet. fabricated from glutaraldehyde-preserved bovine pericardium that in closing meets a pericardiumcovered flexible. Delrin stent. 13 The pericardia! covering of the stent provides a smooth; nonabrasive and throm- From the Departments of Surgery and Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass. Received for publication Feb. 17, Accepted for publication June 11, Address for reprints: Lawrence H. Cohn, MD, Division of Cardiac Surgery, 75 Francis St., Boston, MA 2115 boresistant surface for coaption. The primary goal of a "unicusp" design was to enable the fuil available orifice area at low cardiac outputs (Fig. 1). This study evaluated the hemodynamics and pathologic changes of this valve after mitral and tricuspid valve replacements in sheep. Methods Twenty-nine juvenile sheep weighing 22 to 33 kg (3 to 5 months of age) underwent replacement of the mitral or tricuspid valve. The sheep were divided into three groups. Group 1 was composed of 1 sheep that underwent tricuspid valve replacement with a unileaflet per.icardial valve. Group 2 was composed of nine sheep that underwent mitral valve replacement with a unileaflet pericardia! valve. Group 3 (control) consisted of 1 sheep underwent a tricuspid valve replacement with a trileaflet porcine bioprosthesis. These valves (23 mm) were manufactured by Hancock Extracorporeal, Inc. (Anaheim, Calif.) and were outdated for clinical use (6 years). The animals were anesthetized with thiopental sodium (Pentothal, 25 mgfkg) and anesthesia was maintained with.5% halothane. Cefamandole (5 mgfkg) was administered preoperatively and continued 24 hours postoperatively every 8 hours for antibiotic prophylaxis. All animals received humane care in compliance with the "Principles of Laboratory Animal Care" formulated by the National Society for Medical Research and the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by National Institutes of Health (NIH Publication No. 8-23, revised 1978). Groups 1 and 3: triscupid valve replacement. Animals 912

4 Exh. 23 Page 3 Volume 95 Number 5 May 1988 Unileaflet pericardia/ bioprosthetic valve underwent a right thoracotomy for tricuspid valve replacement. The valve replacement was performed with standard cardiopulmonary bypass technique at normothermia. The tight atrium was opened to expose the tricuspid valve. The leaflets and chordae tendineae were excised. Nonabsorbable pledget-supported suture material was used to suture the valves into the tricuspid valve anulus. Each valve was positioned with the strut posteriorly to avoid outflow tract obstruction. After atriotomy closure, the sheep were weaned from cardiopulmonary bypass. Group 2: Mitral valve replacement. The animals underwent mitral valve replacement via a left thoracotomy. Cardiopulmonary bypass was maintained at 32ac. The aorta was cross-clamped and the heart arrested with 3 ml of cold crystalloid cardioplegic solution. The mitral valve was exposed through a left atriotomy. The valve was excised and the prosthesis sutureq into the mitral valve anulus. The prosthetic valve strut was oriented posteriorly to prevent left ventricular outflow tract obstruction. After 3 months the animals underwent hemodynamic evaluation. The data were collected under basal conditions and then after volume loading with 7 ml of Ringer's lactate. Cardiac output was measured by thermodilution technique. Micromanometer catheters (Millar Instruments, Inc., Houston, Texas) were used to measure intracardiac chamber pressures. Valvular gradients and valve areas were calculated from the h_emodynamic data. 14 Animals were killed at postoperative intervals of 3 to 5 months. The hearts were removed and fixed in 1% formalin. After fixation of the hearts for at least 1 week, the valve prostheses were carefully dissected from the surrounding myocardium with a 1 em cuff of annular tissue. Valves were photographed from the inflow and outflow aspects, roentgenograms were made (25 kv for 1 minute, Faxitron, Hewlett- Packard, McMinnville, Ore.), and sections were taken for histologic examination from the cuspal free edge, both lateral attachments, the cuspal basal attachment; and the inside and outside pericardia! covering of the stationary support. Specimens were dehydrated in graded concentrations of ethanol, embedded in JB-4 glycol methacrylate medium (Polysciences, Inc., Warrington, Pa.), sectioned 2 to 3 P,m thick, and stained by hematoxylin and eosin for overall structure and von Kossa stain for the demonstration of calcium phosphates. The degree of calcification and degree of cuspal stretching and redundancy for each valve were graded as = not present; 4+ = most severe. Gross, microscopic, and radiographic data were recorded on a form designed specifically for analysis of this valve configuration. In vivo hemodynamics Hemodynamic performance of the valves is presented in Table I. The three groups had a mean resting cardiac output of 2.1 ±.15 Ljmin. Mter volume loading with 1 L of Ringer's lactate, the cardiac output was increased in all groups. The 2 f mm unileaflet valve in the tricuspid position had a mean resting gradient of 1.3 ±.6 mm Hg arid a valve area of ±.84 cm 2 Mter volume loading the gradient increased. to 6. ± 1.4 mm Hg and the valve area-increased to 2.63 ±.73 cm 2 The 23 mm unileaftet valve in the mitral position Fig. l. Meadox Medicals heart valve as shown from the outflow aspect (A} and inflow aspect (B). had a resting gradient of 2.4 ±.3 mm Hg and a valve area of 1.97 ±.21 cm 2, which increased to 3.26 ±.41 cm 2 with a rise in gradient to 6.7 ±.6 mm Hg after volume loading. The tricuspid 23 mm porcine bioprosthetic valve in the tricuspid valve position had a resting gradient of 1.8 ±.3 mm Hg and an associated valve area of 1.3 ±.15 _cm 2, which increased to 2.4 ±.32 cm 2 with a rise in valvular gradient to 3.6 ±.9 rrim Hg. Morphology The summary of gross pathologic findings is shown in Table II. Four tricuspid and one mitral unileaftet valve and two porcine tricuspid valves had endocarditis (24%); all were characterized by bulky vegetations involving the cusps of the prosthesis, causing near-complete obstruction. In four of these cases, calcific deposits were noted extrinsic to the cusps, but within the vegetations. These were associated with inflammatory cells or bacteria, or

5 Exh. 23 Page Shemin et a!. The Journal of Thoracic and Cardiovascular Surgery Table I. Hemodynamic evaluation Position size Style (mm) Basal Pericardia! Mitral ±.9 unileaflet Pericardia! Tricuspid ±.22 unileaflet Porcine Tricuspid ±.13 trileaflet *Mean ± standard error of the mean. output (L/min)* Stimulated 3.83 ± ± ±.42.. :; area Basal Stimulated 1.97 ± ± ± ± ± ±.32 Basal Stimulated 2.4 ± ± ±.6 6. ± ± ±.9 Table IT. Summary of pathologic results Thrombosis Endocarditis Calcification* Cuspal stretching* Porcine (T} 2/1 2/8 T, Tricuspid position; M, mitral position. *Includes noninfected specimens only. tone with paravalvular leak. Unileaflet (T) 4/1 4/6 6/6 Unileaflet (M) 1/9 7/8 7f8t both. Valves with infection are not included in the subsequent analysis. No instance of thrombotic occlusion was encountered and there were no grossly visible valvular thrombotic deposits. The mean (range) implantation intervals for noninfected porcine tricuspid, unileaflet tricuspid, and unileaflet mitral valves were 132 (17 to 161) days, 17 (99 to 119) days, and 123 (14 to 159) days, respectively. Intrinsic cuspal calcification was noted grossly, radiographically, and histologically in four of six unileaflet tricuspid valves, seven of eight unileaflet mitral valves, but only two of eight porcine tricuspid valves (Figs. 2, 3, and 4). Gross and radiographic features of valve mineralization are illustrated in Fig. 2. Although the number of valves is relatively small, the degree of calcification graded radiographically, and summarized in Fig. 3, was greater in mitral (range to 3+, median 2+) than tricuspid replacements (range to 1 +, median 1 + ); both were more than that noted in the porcine control valves in this study (range to 1 +,median ). Three of eight unileaflet mitral but no unileaflet or porcine tricuspid valves had 3+ calcification. The major site of calcification of the unicuspal pericardia! bioprosthesis was along the linear attachments of the mobile cusp to the fixed strut. Histologic examination revealed that calcium phosphate deposition in unileaflet bioprostheses was generally intrinsic to the cuspal pericardium (Fig. 4), but occasionally extrinsic where calcium ulcerated through the cuspal surface. Extrinsic mineralization was often associated with focal microscopic thrombotic deposits. The stationary pericardia! covering of the fixed strut had minimal and focal intrinsic microscopic calcification, which was limited to the sites of suture compression. There was,. in general, good correlation noted in the degree of mineralization revealed by the various techniques used for analysis. Neither cuspal tearing nor perforations were noted. However, most pericardia! unileaflet valves (six tricuspid, seven mitral) had some degree of stretching and redundancy of the mobile cusp, particularly at its free edge (Figs. 5 and 6), the severity varying among specimens (tricuspid, range 1 + to 3+, median 2+; mitral, range 1 + to 4+, median 2 +). In some cases, cuspal stretching appeared to be sufficient to have caused valvular incompetency, although not of a degree sufficient to cause prolapse of the mobile cusp. Gross pericardia! cuspal redundancy correlated well with the microscopic appearance of distorted and separated collagen bundles (Fig. 5). This was not associated with inflammation or calcification. Redundancy of cusps was not encountered in the porcine bioprostheses studied. Tissue overgrowth was generally mild and did not contribute to dysfunction of any _prosthesis. In one case, calcification was also seen as extrinsic microfoci, associated with tissue overgrowth at the proximal portion of the mobile cusp. Small foci of fibrous tissue were frequently noted overlying the proximal attachment sites and distal free edges of cusps. Microscopically, especially at the free edges, there was inflammatory infiltration of the cuspal tissue by mononuclear cells, predominantly macrophages, which interdigitated among the cuspal collagen bundles and focally destroyed the cuspal architecture (Fig. 7). Cuspal inflammatory activity, gross

6 Exh. 23 Page 5 Volume 95 Number 5 May 1988 Unileaflet pericardia! bioprosthetic valve Fig. 2. Gross and radiographic features of the mineralization of unileaflet pericardia! valves used. Unileaflet pericardia! bioprostheses implanted in the tricuspid (A) and mitral (C) positions, with their associated specimen radiographs, B and D, respectively. Mineralization sites are indicated by arrows in radiographs. distortion with microscopic architectural disruption, and deposition of calcific nodules appeared to be independent processes, each feature generally noted separately from the others. Discussion The present study provides a detailed hemodynamic and pathologic analysis of a new unileaflet glutaraldehyde-pretreated pericardia! bioprosthesis implanted into and harvested from growing sheep. The methods used demonstrate a comprehensive approach to the study of a new bioprosthesis of any configuration. All animals did well during the period of observation, with each animal at least doubling its body weight. Congestive heart failure or thromboembolic episodes were not present. The hemodynainic performance of the PORCINE VALVE (T) z 4 8 UNILEAFLET (T) A UNILEAFLET (M) -u LL..- -I 3 Ua_...Jq: <ta:: Ue> u...o oo w<f: wa:: (!) w 2,. A I.u..e, 1 eo, QO DURATION (DAYS) A- 161 o-- Q 15 MEAN VALUES Fig. 3. Summary of radiographically determined degree of calcification versus duration of implant for the valves analyzed. T, Tricuspid position; M, mitral position..a

7 Exh. 23 Page Shemin eta!. The Journal of Thoracic and Cardiovascular Surgery Fig. 4. Microscopic features of unileaflet pericardia! valve mineralization. A, Intrinsic cuspal calcification (from specimen shown in Fig. 2, C and D). B, Extrinsic calcification (e) (valve cusp noted by asterisk), superimposed on intrinsic calcification (i). C, Focal mineralization associated with the anchoring suture (s) in pericardium covering stationary strut. (Von Kossa's reagent [calcium phosphate black]; original magnifications; A, Xl35; B, and C, X 5.) pericardia! unileafiet valve was satisfactory in both the mitral and tricuspid positions. All groups had low resting gradients and responded to volume loading with an increase in the effective valve orifice area. This finding has been noted in tissue valves and is probably due to improved leaflet excursion at higher cardiac output. 15 The trileafiet porcine valve in the tricuspid position demonstrated satisfactory hemodynamics. During the limited period of observation, the hemodynamic function of the prosthesis was not significantly affected by the pathologic changes. However, the morphologic results suggest that this prosthesis may be subject to several distinct degenerative processes in clinical use. Calcification was prominent, especially in the mitral valve replacements. Since presently used clinical porcine and pericardia! bioprostheses fail frequently by calcific degeneration, the results of this study suggest that the durability of the unileafiet pericardia! bioprosthesis would be limited by this pathologic process Recent studies of calcification of glutaraldehyde-preserved pericardium implanted subcutaneously in rats have suggested that. the potential for and the mechanisms of mineralization of bovine pericardium are identical to those of similarly prepared porcine aortic valves, 2 despite the structural differences between these materials The present study also suggests that calcification of the stationary pericardia! strut covering, which occurred only focally in association with sutures, will not be an important problem. Local inflammatory tissue destruction and pericardia! stretching with redundancy were unexpected findings of this study. The significance of pericardia! inflammation

8 Exh. 23 Page 7 volume 95 Number 5 MaY 1988 Unileaflet pericardia/ bioprosthetic valve '.. '. Fig. 5. Stretching of pericardium. Gross photographs (A and B) and photomicrograph (C) showing severe cuspal stretching and redundancy, associated with local pericardia! architectural disruption and separation of collagen bundles. C, Hematoxylin and eosin; original magnification X 15.) and gross stretching with redundancy is unknown. Superficial mononuclear cells are frequently noted in clinical porcine aortic valve bioprostheses implanted for long intervals, but neither inflammatory destruction nor cuspal distortion has been previously reported in orthotopic experimental, human pericardia!, or porcine valve explants. 19 However, these processes have recently been noted in failed clinical pericardia! bioprostheses. 24 The cause of pericardia! stretching is unknown. It could be a general property of this tissue, or it could be a product of peculiarities of tissue selection site or orientation, or of changes during tissue preparation. In this regard, a recent study demonstrated that the extensibility of tissue harvested from one particular site within the calf pericardium was significantly greater than that from all <.!) ' z 4 J: " w ::>- 1-u 3 rnz...jc:x c:xa -e-, a.z (f)::> =>a 2 uw IJ...cr yb- w w ::. <.!) w a PORCINE (T) UNICUSPID(T) UNICUSPID (M) Fig. 6. Summary of degree of pericardia! stretching/redundancy for the valves examined. T, Tricuspid position; M, mitral position.

9 Exh. 23 Page Shemin et a/. The Journal ot Thoracic and Cardiovascular Surgery report demonstrating a significant decrease in amount of calcification in porcine valve and pericardia! tissues stored in glutaraldehyde for increasing periods after 15 months. 3 Thus, despite favorable hemodynamics, the unicusp pericardia! valve will likely have limited durability because of multiple modes of tissue degeneration. The reported herein support accumulating data that pericardium may be. less durable than porcine aortic valve, and that valves fabricated from bovine pericardium may be subject to a variety of potentially deleterious degenerative processes Fig. 7. Photomicrograph of fibrous capsule associated with inflammatory infiltration and local cuspal destruction. Individual collagen bundles are noted by arrows. (Hematoxylin and eosin; original magnification X375.) other positions. 25 Tissue from this site, however, was not unusual with respect to thickness or structure on light and electron microscopic study. Destruction of pericardium by inflammation has been also noted in studies of subcutaneous implants of pericardium. 2. Although bioprosthetic valve mineralization does riot appear to have an immunologic basis, 26 it is possible that noncalcific inflammatory reactivity may be related to an immunologic reaction directed toward collagen or some other component of pericardia! tissue. Orthotopic experimental valve replacements in calves, sheep, and dogs have been used recently as an adjunct to prosthetic valve development. Since the durability of clinical bioprosthetic valves is most significantly limited by mineralization, with or without associated cuspal tearing, a modd used to investigate the suitability of a new bioprosthetic valve configuration must use an immature subject of a species that potentiates calcification.27 Growing sheep, as used in the present study, have been found to be a convenient and reliable model for bioprosthesis evaluation, in which valves of 21 to 23 mm may be inserted in both the tricuspid and mitral positions, and the animals observed for periods of 3 to 6 months. A previous investigation of the unileaflet valve configuration in dogs did riot demonstrate significant calcification despite 2 years of valve function The dog is not generally considered to be a useful model for accelerated calcification. The minimal pathologic changes in all the porcine valves studied were striking. The8e valves were outdated for clinical use. This observation is consistent with a REFERENCES 1. Carpentier A, Deloche A, Relland J, et al. Six-year follow-up of glutaraldehyde-preserved heterografts. J THORAC CARDIOVASC SURG 1974;68: Oyer PE, Stinson EB, Griepp RB, Shumway NE. Valve replacement with the Edwards and Hancock prosthesis: comparative analysis of late morbidity and mortality. Ann Surg 1977;186: Pipkin RJ), Buch WS, Fogarty TJ. Evaluation of aortic valve replacement with a porcine xenograft without long-term anticoagulation. J THORAC CARDIOVASC SURG 4. Ferrans VJ, Boyce SW, Billingham ME, Jones M, Ishihara T, Roberts WC. Calcific deposits in porcine bioprostheses: structure and pathogenesis. Am J Cardiol 198;46: Ferrans VJ, Spray TL, Billingham ME, Roberts WC. Structural changes in glutaraldehyde-treated porcine heterografts used as substitute cardiac valves. Am J Cardiol 1978;41: Fishbein MC, Gissen SA, Collins JJ, Barsamian EM, Cohn LH. Pathologic findings after cardiac valve replacement with glutaraldehyde-fixed porcine valves. Am J Cardiol 1977;4: Riddle JM, Magilligan DJ Jr, Stein PD. Surface morphology of degenerated porcine bioprosthetic valves four to seven years following implantation. J THORAC CARDIO VASCSURG 1981;81: Magilligan DJ Jr, Lewis JW Jr, Jara FM, et al. Spontaneous degeneration of porcine bioprosthetic valves. Ann Thorac Surg 198.;3: Sanders SP, Levy RJ, Freed MD, Norwood WI, Castaneda AR. Use of Hancock porcine xenografts in children and adolescents. Ani J Cardiol 198;46: Kutsche LM, Oyer P, Shumway N, Baum D. An important complication of Hancock mitral valve replacement in children. Circulation 1979;6(Pt 2): Carpentier A, Dubost C, Lane E, et al. Continuing improvements in valvular bioprostlieses. J THoRAC CAR DIOVASC SURG 1982;83: Levy RJ, Hawley MA, Schoen FJ, Lund SA, Liu PY.

10 Exh. 23 Page 9 volume 95 Number 5 MaY 1988 Unileaflet pericardia! bioprosthetic valve Inhibition by diphosphonate compounds of calcification of porcine bioprosthetic heart valve cusps implanted subcutaneously in rats. Circulation 1985;71 : Gabbay S. Ionescu-Shiley pericardia! xenograft: followup of 1 year to 6 years. Ann Thorac Surg 1985;39: Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. Am Heart J 1?51;41: Ubago JL, Figueroa A, Colman T, Revuelta JM, Ochoteco A, Duran CMG. Hemodynamic evaluation of the Hancock bioprosthesis in the mitral position: a 1-7 year follow-up. In: Cohn LH, Gallucci V, eds. Cardiac biopros.:. theses. New York: Yorke Medical Books, 1982: Schoen FJ, Levy RJ. Bioprosthetic heart valve failure: pathology and pathogenesis. Cardiol Clin 1984;2: Milano A, Bortolotti U, Talenti E, et al. Calcific degeneration as the main cause of porcine bioprosthetic valve dysfunction. Am J Cardiol 1984;53: Schoen FJ, Hobson CE. Anatomic analysis of removed prosthetic heart valves: causes of failure of 33 mechanical valves and 58 bioprostheses, Hum Pathol 1985; 16: Schoen FJ. Cardiac valve prosthesis: pathological and bioengineering considerations. J Cardiac Surg 1987;2: Schoen FJ, Tsao JW, Levy RJ. Calcification of bovine pericardium used in cardiac valve bioprosthesis: implications for the mechanisms of bioprosthetic tissue mineralization. Am J Pathol 1986;123: Ishihara T, Ferrans VJ, Jones M, Boyce SW, Kawanami, Roberts WC. Histologic and ultrastructural featuresof normal human parietal pericardium. Am J Cardiol 198; 46: Ishihara T, Ferrans VJ, Jones M, Boyce SW, Roberts WC. Structure of bovine parietal pericardium and of unimplanted Ionescu-Shiley pericardia! valvular bioprostheses. J THORAC CARDIOVASC SURG 1981;81: Allen DJ, DiDio LJ, Zacharias A, et al. Microscopic study of normal parietal pericardium and unimplanted Puig-Zerbini pericardia! valvular heterografts. J THoRAc CARDIOVASC StiRG 1984;87: Schoen J, Gonzalez-Lavin L, Cernaianu A. Causes of m1d pathologic findings in surgically removed standard bovine pericardia! heart valve emphasis on progressive structural deterioration. Circulation 1987;76: Trowbridge EA, Roberts KM, Crofts CE, Lawford PV. Pericardia! heterografts: toward quality control of the mechanical properties of glutaraldehyde-fixed leaflets. J THORAC CARDIOVASC SURG 1986;92: Levy RJ, Schoen FJ, Howard SL. Mechanism of calcification of porcine bioprosthetic aortic valve cusps: role of T-lymphocytes. Am J Cardiol 1983;52: Jones M, Barnhart GR, Chavez JM, et al. Experimental evaluation of bioprosthetic valves implanted in sheep. In: Cohn LH, Gallucci V, eds. Cardiac bioprotheses. New York: Yorke Medical Books, 1982: Gabbay S, Frater RWM. The unileaflet heart valve bioprosthesis: new concept. In: Cohn LH, Gallucci V, eds. Cardiac bioprostheses. New York: Yorke Medical Books, 1982: Gabbay S, Frater RWM. The Meadox uni-cusp heart valve bioprosthesis. L'Informaticin Cardiol 1983 (July- August): Schryer PJ, Tomasek ER, Starr JA, Wright JTM. Anti-calcification effect of glutaraldehyde-preserved valve tissue stored for increasing time in glutaraldehyde, In: Bodnar E, Yacoub M, eds. Biologic and bioprosthetic valves, New York: Yorke Medical Books, 1986: Reul GJ, Cooley DA, Duncan JM, et al. Valve failure with the Ionescu-Shiley bovine pericardia! bioprosthesis: analysis of 268 patients. J Vase Surg 1985;2: Galioto FM, Midgley FM, Kapur S, et al. Early failures of Ionescu-Shiley bioprosthesis after mitral valve replacement in children. J THORAC CARDIOVASC SuRG 1982; 83: Gallo I, Nistal F, Revuelta JM, Garcia-Satue E, Artifiano E, Duran CG. Incidence of primary tissue valve failure with the Ionescu-Shiley pericardia! valve. J THORAC CARDIOVASC SURG 1985;9: Walley VM, Bedard P, Brais M, Keon WJ. Valve failure caused by cusp tears in low-profile Ionescu-Shiley bovine pericardia! bioprosthetic valves. J THo RAe CARDiov ASC SuRG 1987;93:583-6.

Degeneration and Cacfi cation of Bioprosthetic Cardiac Valves

Degeneration and Cacfi cation of Bioprosthetic Cardiac Valves ANIMAL MODEL OF HUMAN DISEASE Degeneration and Cacfi cation of Bioprosthetic Cardiac Valves Bioprosthetic Tricuspid Valve Implantation in Sheep GLENN R. BARNHART, MD, MICHAEL JONES, MD, TOKUHIRO ISHIHARA,

More information

Primary Tissue Valve Degeneration in Glutaraldehvde-Preserved Porcine Biomostheses: Hancock I Vekus Carpentier-Edwards at 4- to 7-Years Follow-up

Primary Tissue Valve Degeneration in Glutaraldehvde-Preserved Porcine Biomostheses: Hancock I Vekus Carpentier-Edwards at 4- to 7-Years Follow-up Primary Tissue Valve Degeneration in Glutaraldehvde-Preserved Porcine Biomostheses: A Hancock I Vekus Edwards at 4- to 7-Years Follow-up Francisco Nistal, M.D., Edurne Artifiano, M.D., and Ignacio Gallo,

More information

P have been used for mitral and aortic valve replacement

P have been used for mitral and aortic valve replacement A -Year Comparison of Mitral Valve Replacement With Carpentier-Edwards and Hancock Porcine Bioprostheses P. Perier, MD, A. Deloche, MD, S. Chauvaud, MD, J. C. Chachques, MD, J. Relland, MD, J. N. Fabiani,

More information

Relation of Calcification to Tom Leaflets

Relation of Calcification to Tom Leaflets Relation of Calcification to Tom Leaflets of Spontaneously Degenerated Porcine Bioprosthetic Valves Paul D. Stein, M.D., Stephen R. Kemp, Ph.D., Jeanne M. Riddle, Ph.D., Min W. Lee, M.D., Joseph W. Lewis,

More information

Late failure of transcatheter heart valves: An open question

Late failure of transcatheter heart valves: An open question Late failure of transcatheter heart valves: An open question A comparison with surgically implanted bioprosthetic heart valves. A. Rashid The Cardiothoracic Centre Liverpool, UK. Conflict of Interest Statement

More information

by Age Groups W. R. E. Jamieson, M.D., L. J. Rosado, M.D., A. I. Munro, M.D., A. N. Gerein, M.D., L. H. Burr, M.D., R. T. Miyagishima, M.D.

by Age Groups W. R. E. Jamieson, M.D., L. J. Rosado, M.D., A. I. Munro, M.D., A. N. Gerein, M.D., L. H. Burr, M.D., R. T. Miyagishima, M.D. Carpentier-Edwards Standard Porcine Bioprosthesis: Primary Tissue Failure (Structural Valve Deterioration) by Age Groups W. R. E. Jamieson, M.D., L. J. Rosado, M.D., A. I. Munro, M.D., A. N. Gerein, M.D.,

More information

Isolated Mitral Valve Replacement with the Hancock Bioprosthesis: A 13-Year Appraisal

Isolated Mitral Valve Replacement with the Hancock Bioprosthesis: A 13-Year Appraisal Isolated Mitral Valve Replacement with the Hancock ioprosthesis: A 13-Year Appraisal Vincenzo Gallucci, M.D., berto ortolotti, M.D., Aldo Milano, M.D., Carlo Valfrk, M.D., Alessandro Mazzucco, M.D., and

More information

P substitutes since the introduction of the Ionescu-

P substitutes since the introduction of the Ionescu- Mitroflow Pericardial Valve: Long-Term Durability Daniel Y. Loisance, MD, Jean-Philippe Mazzucotelli, MD, Patrick C. Bertrand, MD, Philippe H. Deleuze, MD, and Jean-Paul Cachera, MD Department of Surgical

More information

I will not discuss off label use or investigational use in my presentation.

I will not discuss off label use or investigational use in my presentation. I will not discuss off label use or investigational use in my presentation. Surgical valves Design and Durability Testing Potential Concerns Real Practice 1952-1962 1963-1966 1967-1969 1969-1977 1977-1984

More information

Echocardiographic Evaluation of Mitral Valve Prostheses

Echocardiographic Evaluation of Mitral Valve Prostheses Echocardiographic Evaluation of Mitral Valve Prostheses Dennis A. Tighe, M.D., FACC, FACP, FASE Cardiovascular Medicine University of Massachusetts Medical School Worcester, MA www.asecho.org 1 Nishimura

More information

Aspirin or Coumadin as the Drug of Choice

Aspirin or Coumadin as the Drug of Choice Aspirin or Coumadin as the Drug of Choice for Valve Replacement with Porcine Bioprosthesis L. Nufiez, M.D., M. Gil Aguado, M.D., D. Celemin, M.D., A. Iglesias, M.D., and J. L. Larrea, M.D. ABSTRACT Eight

More information

Carpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience

Carpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://www.annalsthoracicsurgery.org/cme/ home. To take the CME activity related to this article, you must have either an STS member

More information

Dvnamic Behavior of Prosthetic Aortic Tissue Vdves as Viewed by High-speed Cinematography

Dvnamic Behavior of Prosthetic Aortic Tissue Vdves as Viewed by High-speed Cinematography Dvnamic Behavior of Prosthetic Aortic Tissue Vdves as Viewed by High-speed Cinematography W. Gerald Rainer, M.D., Robert A. Christopher, Ph.D., Theodore R. Sadler, Jr., M.D., and Alan D. Hilgenberg, M.D.

More information

15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses

15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses ORIGINAL CONTRIBUTION 15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses WR Eric Jamieson, MD, Eva Germann, MSc, Michel R Aupart, MD 1, Paul H Neville, MD 1, Michel A Marchand,

More information

Iatrogenic pathology of the heart:

Iatrogenic pathology of the heart: Iatrogenic pathology of the heart: Complications of mitral valve plasty and replacement Patrick Bruneval D pt of Pathology Hôpital Européen Georges Pompidou Enterprise Interest None Mitral valve surgery

More information

Durability of Pericardial Versus Porcine Aortic Valves

Durability of Pericardial Versus Porcine Aortic Valves Journal of the American College of Cardiology Vol. 44, No. 2, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.01.053

More information

P found suitable valve substitutes for clinical use.

P found suitable valve substitutes for clinical use. Porcine Versus Pericardial Bioprostheses: A Comparison of Late Results in 1,593 Patients L. Conrad Pelletier, MD, Michel Carrier, MD, Yves Leclerc, MD, Gilles Lepage, MD, Pierre deguise, MD, and Ihor Dyrda,

More information

AORTIC VALVE REPLACEMENT WITH FREEHAND AUTOLOGOUS PERICARDIUM

AORTIC VALVE REPLACEMENT WITH FREEHAND AUTOLOGOUS PERICARDIUM AORTIC VALVE REPLACEMENT WITH FREEHAND AUTOLOGOUS PERICARDIUM Fifty-one patients with a mean age of 31.2 years underwent aortic valve replacement with glutaraldehyde-treated autologous pericardium. Pure

More information

Animal Evaluation of a New Pericardial Bioprosthe tic Heart Valve

Animal Evaluation of a New Pericardial Bioprosthe tic Heart Valve xh. 2008 Page 1 Artificial Organs 12(4):328-336, Raven Press, Ltd., New York 6 1988 nternational Society for Artificial Organs Animal valuation of a New Pericardial Bioprosthe tic Heart Valve T. J. Spyt,

More information

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical

More information

T sors in the following aspects: the porcine aortic valve

T sors in the following aspects: the porcine aortic valve Clinical and Hemodynamic Assessment of the Hancock I1 Bioprosthesis Tirone E. David, MD, Susan Armstrong, MSc, and Zhao Sun, MA Division of Cardiovascular Surgery, The Toronto Hospital and University of

More information

Reconstruction of the intervalvular fibrous body during aortic and

Reconstruction of the intervalvular fibrous body during aortic and Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body: An analysis of clinical outcomes Nilto C. De Oliveira, MD Tirone E. David, MD Susan Armstrong, MSc Joan Ivanov,

More information

CARPENTIER-EDWARDS PERICARDIAL VALVES IN THE MITRAL POSITION: TEN-YEAR FOLLOW-UP

CARPENTIER-EDWARDS PERICARDIAL VALVES IN THE MITRAL POSITION: TEN-YEAR FOLLOW-UP CARPENTIER-EDWARDS PERICARDIAL VALVES IN THE MITRAL POSITION: TEN-YEAR FOLLOW-UP M. R. Aupart, MD P. H. Neville, MD S. Hammami, MD A. L. Sirineili, MD Y. A. Meurisse, MD M. A. Marchand, MD Objective: The

More information

PATIENT BOOKLET MEDTRONIC SURGICAL VALVE REPLACEMENT. Tissue Valve for Aortic and Mitral Valve Replacement

PATIENT BOOKLET MEDTRONIC SURGICAL VALVE REPLACEMENT. Tissue Valve for Aortic and Mitral Valve Replacement PATIENT BOOKLET MEDTRONIC SURGICAL VALVE REPLACEMENT Tissue Valve for Aortic and Mitral Valve Replacement ARE MEDTRONIC SURGICAL TISSUE HEART VALVES RIGHT FOR YOU? Medtronic surgical heart valves are for

More information

Onset and progression of calcification in porcine aortic bioprosthetic valves implanted as orthotopic mitral valve replacements in juvenile sheep

Onset and progression of calcification in porcine aortic bioprosthetic valves implanted as orthotopic mitral valve replacements in juvenile sheep Onset and progression of calcification in porcine aortic bioprosthetic valves implanted as orthotopic mitral valve replacements in juvenile sheep The purpose of this study was to characterize the onset

More information

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve

More information

A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis

A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis Acquired Cardiovascular Disease Mykén and Bech-Hansen A 2-year experience of 1712 patients with the Biocor porcine bioprosthesis Pia S. U. Mykén, MD, PhD, a and Odd Bech-Hansen, MD, PhD b Objective: The

More information

CLINICAL COMMUNIQUE 16 YEAR RESULTS

CLINICAL COMMUNIQUE 16 YEAR RESULTS CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced

More information

Research Article Evolving Bioprosthetic Tissue Calcification Can Be Quantified Using Serial Multislice CT Scanning

Research Article Evolving Bioprosthetic Tissue Calcification Can Be Quantified Using Serial Multislice CT Scanning International Biomaterials Volume 2013, Article ID 617329, 7 pages http://dx.doi.org/10.1155/2013/617329 Research Article Evolving Bioprosthetic Tissue Calcification Can Be Quantified Using Serial Multislice

More information

Long-term Hemodynamic Assessment of the Porcine Heterograft in the Mitral Position

Long-term Hemodynamic Assessment of the Porcine Heterograft in the Mitral Position Long-term Hemodynamic Assessment of the Porcine Heterograft in the Mitral Position Late Development of Valvular Stenosis LEWIS C. LIPSON, M.D., KENNETH M. KENT, M.D., PH.D., DOUGLAS R. ROSING, M.D., ROBERT

More information

The St. Jude Medical Biocor Bioprosthesis

The St. Jude Medical Biocor Bioprosthesis The St. Jude Medical Biocor Bioprosthesis Clinical Evidence of Long-term Durability Long-term Biocor Experience A Review and Comparative Assessment Long-term Biocor Stented Tissue Valve Studies Twenty-year

More information

The vast majority of patients, especially children, who

The vast majority of patients, especially children, who Technique of Mechanical Pulmonary Valve Replacement John M. Stulak, MD, and Joseph A. Dearani, MD The vast majority of patients, especially children, who require pulmonary valve replacement (PVR), obtain

More information

14 Valvular Stenosis

14 Valvular Stenosis 14 Valvular Stenosis 14-1. Valvular Stenosis unicuspid valve FIGUE 14-1. This photograph shows severe valvular stenosis as it occurs in a newborn. There is a unicuspid, horseshoe-shaped leaflet with a

More information

42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim

42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim 42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim Current Guideline for AR s/p TOF Surgery is reasonable in adults with prior repair of

More information

Clinical material and methods. Copyright by ICR Publishers 2003

Clinical material and methods. Copyright by ICR Publishers 2003 Fourteen Years Experience with the CarboMedics Valve in Young Adults with Aortic Valve Disease Jan Aagaard 1, Jens Tingleff 2, Per V. Andersen 1, Christel N. Hansen 2 1 Department of Cardio-Thoracic and

More information

Trifecta Valve. Clinical Compendium. Five Year Data

Trifecta Valve. Clinical Compendium. Five Year Data Trifecta Valve Clinical Compendium Five Year Data Trifecta Valve Compendium INTRODUCTION The Trifecta valve is a tri-leaflet stented pericardial valve designed for supra-annular placement in the aortic

More information

and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D.

and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D. Combined Valvular and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D. ABSTRACT Between July, 97, and March, 975,45 patients underwent combined valvular

More information

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Decision process for Management of any valve Timing Feasibility

More information

Late Results with Autogenous

Late Results with Autogenous Late Results with Autogenous Tissue Heart Valves W. Sterling Edwards, M.D. ABSTRACT Five years of experience using unsupported and mounted fascia lata and pericardial heart valves in human beings is summarized.

More information

CONTRIBUTION. Aortic valve replacement in young patients: long-term follow-up

CONTRIBUTION. Aortic valve replacement in young patients: long-term follow-up CONTRIBUTION Aortic valve replacement in young patients: long-term follow-up DOUGLAS S. MOODIE, MD; USAMA HANHAN, MD; RICHARD STERBA, MD; DANIEL J. MURPHY, Jr, MD; ELIOT R. ROSENKRANZ, MD; ANDREA M. KOVACS,

More information

452 lacc Vol 2. No 3 September

452 lacc Vol 2. No 3 September 452 lacc Vol 2. No 3 September 1983.452-9 Detection of Deterioration or Infection of Homograft and Porcine Xenograft Bioprosthetic Valves in Mitral and Aortic Positions by Two-Dimensional Echocardiographic

More information

Controversy exists regarding which valve type is best

Controversy exists regarding which valve type is best Treatment of Endocarditis With Valve Replacement: The Question of Tissue Versus Mechanical Prosthesis Marc R. Moon, MD, D. Craig Miller, MD, Kathleen A. Moore, BS, Phillip E. Oyer, MD, PhD, R. Scott Mitchell,

More information

Replacement of the mitral valve in the presence of

Replacement of the mitral valve in the presence of Mitral Valve Replacement in Patients with Mitral Annulus Abscess Christopher M. Feindel Replacement of the mitral valve in the presence of an abscess of the mitral annulus presents a major challenge to

More information

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for

More information

Autologous Pulmonary Valve Replacement of the Diseased Aortic Valve

Autologous Pulmonary Valve Replacement of the Diseased Aortic Valve Autologous Pulmonary Valve Replacement of the Diseased Aortic Valve By L. GONZALEZ-LAvIN, M.D., M. GEENS. M.D., J. SOMERVILLE, M.D., M.R.C.P., ANm D. N. Ross, M.B., CH.B., F.R.C.S. SUMMARY Living tissue

More information

Presenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose

Presenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material

More information

Adult Cardiac Surgery

Adult Cardiac Surgery Adult Cardiac Surgery Mahmoud ABU-ABEELEH Associate Professor Department of Surgery Division of Cardiothoracic Surgery School of Medicine University Of Jordan Adult Cardiac Surgery: Ischemic Heart Disease

More information

Porcine Valve Durability in Children

Porcine Valve Durability in Children Porcine Valve Durability in Children Jeffrey M. Dunn, M.D.* ABSTRACT Calcification of porcine heterograft valves may be greater in the pediatric than in the adult population. This multicenter study evaluates

More information

Calcification of Bovine Pericardium: Glutaraldehyde Versus No-React Biomodification

Calcification of Bovine Pericardium: Glutaraldehyde Versus No-React Biomodification Calcification of Bovine Pericardium: Glutaraldehyde Versus No-React Biomodification Amir Abolhoda, MD, Sumei Yu, MS, J. Rodrigo Oyarzun, MD, John R. McCormick, MD, John D. Bogden, PhD, and Shlomo Gabbay,

More information

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction

More information

The Last Generation of Pericardial Valves in the Aortic Position: Ten-Year Follow-up in 589 Patients

The Last Generation of Pericardial Valves in the Aortic Position: Ten-Year Follow-up in 589 Patients The Last Generation of Pericardial Valves in the Aortic Position: Ten-Year Follow-up in 589 Patients Michel R. Aupart, MD, Agnes L. Sirinelli, MD, Frank F. Diemont, MD, Yvon A. Meurisse, MD, Xavier B.

More information

CoreValve in a Degenerative Surgical Valve

CoreValve in a Degenerative Surgical Valve CoreValve in a Degenerative Surgical Valve Ran Kornowski, MD, FESC, FACC Chairman Department of Cardiology Rabin Medical Center, Petach Tikva, Israel Disclosure Statement of Financial Interest I, Ran Kornowski,

More information

Echo Evaluation of a Mitral Valve Prostheses Sunday, February 14, :50 2:10 PM 20 min

Echo Evaluation of a Mitral Valve Prostheses Sunday, February 14, :50 2:10 PM 20 min 2016 ASE State of the Art Echocardiography Course Tucson, AZ Echo Evaluation of a Mitral Valve Prostheses Sunday, February 14, 2016 1:50 2:10 PM 20 min 1 M U H A M E D S A R I Ć, M D, P H D D i r e c t

More information

M over replacement with an artificial device. For

M over replacement with an artificial device. For Artificial Mitral Valve Chordae: Experimental and Clinical Experience Claudio Zussa, MD, Robert W. M. Frater, MD, Elvio Polesel, MD, Marco Galloni, BS, and Carlo Valfrk, MD Division of Cardiac Surgery,

More information

Degenerative aortic valve (AV) stenosis is the most

Degenerative aortic valve (AV) stenosis is the most Crimping May Affect the Durability of Transcatheter Valves: An Experimental Analysis ADULT CARDIAC Philipp Kiefer, MD, Felix Gruenwald, Joerg Kempfert, MD, Heike Aupperle, PhD, Joerg Seeburger, MD, Friedrich

More information

Read at the Twenty-fourth Annual Meeting of The Western Thoracic Surgical Association, Whistler, British Columbia, June 24-27, 1998.

Read at the Twenty-fourth Annual Meeting of The Western Thoracic Surgical Association, Whistler, British Columbia, June 24-27, 1998. STRUCTURAL VALVE DETERIORATION IN MITRAL REPLACEMENT SURGERY: COMPARISON OF CARPENTIER-EDWARDS SUPRA-ANNULAR PORCINE AND PERIMOUNT PERICARDIAL BIOPROSTHESES W. R. Eric Jamieson, MD a Michel A. Marchand,

More information

Disease of the aortic valve is frequently associated with

Disease of the aortic valve is frequently associated with Stentless Aortic Bioprosthesis for Disease of the Aortic Valve, Root and Ascending Aorta John R. Doty, MD, and Donald B. Doty, MD Disease of the aortic valve is frequently associated with morphologic abnormalities

More information

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)

More information

Pulmonary Valve Replacement

Pulmonary Valve Replacement Pulmonary Valve Replacement with Fascia Lata J. C. R. Lincoln, F.R.C.S., M. Geens, M.D., M. Schottenfeld, M.D., and D. N. Ross, F.R.C.S. ABSTRACT The purpose of this paper is to describe a technique of

More information

Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years experience in 130 patients

Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years experience in 130 patients Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years experience in 130 patients Augusto D Onofrio, MD, Stefano Auriemma, MD, Paolo Magagna, MD, Alessandro Favaro, MD,

More information

J. Y. Jung, M.D., A. G. Fabaz, D.O., P. Michael McFadden, M.D., Betty Lewis, R.N., and George Daughters, M.S.

J. Y. Jung, M.D., A. G. Fabaz, D.O., P. Michael McFadden, M.D., Betty Lewis, R.N., and George Daughters, M.S. Five-Year Experience with the Ionescu-Shiley Bovine Pericardial Valve in the Aortic Position Lorenzo Gonzalez-Lavin, M.D., Seong Chi, M.D., T. Calvin Blair, M.D., J. Y. Jung, M.D., A. G. Fabaz, D.O., P.

More information

The need for right ventricular outflow tract reconstruction

The need for right ventricular outflow tract reconstruction Polytetrafluoroethylene Bicuspid Pulmonary Valve Implantation James A. Quintessenza, MD The need for right ventricular outflow tract reconstruction and pulmonary valve replacement is increasing for many

More information

Indications and Late Results of Aortic Valve Repair

Indications and Late Results of Aortic Valve Repair Indications and Late Results of Aortic Valve Repair Prof. Gebrine El Khoury Department of Cardiovascular and Thoracic Surgery Cliniques St. Luc Brussels, Belgium Aortic Valve Repair Question # 1 Can the

More information

The Starr-Edwards Valve

The Starr-Edwards Valve lacc Vol. 6, No.4 899 The Starr-Edwards Valve ALBERT STARR, MD, FACC Portland, Oregon This report reviews the results obtained with the current models of the Silastic ball valve, classifying the experience

More information

Repeated mitral valve replacement in a patient with extensive annular calcification

Repeated mitral valve replacement in a patient with extensive annular calcification CASE REPORT Open Access Repeated mitral valve replacement in a patient with extensive annular calcification Tadashi Kitamura 1,2*, Sachito Fukuda 1, Takahiro Sawada 1, Sumio Miura 1, Ikutaro Kigawa 1,3

More information

The Phvsical Properties of Bovine Pericardium: A Stud? of the Elffects of Stretching during Chemical Treatment in Glutaraldehyde

The Phvsical Properties of Bovine Pericardium: A Stud? of the Elffects of Stretching during Chemical Treatment in Glutaraldehyde The Phvsical Properties of Bovine Pericardium: A Stud? of the Elffects of Stretching during Chemical Treatment in Glutaraldehyde I. J. Reece, M.B., F.R.C.S., R. van Noort, B.Sc., D.Phil., T. R. P. Martin,

More information

Are Stented Bioprostheses Appropriate for Aortic Valve Replacement in Young Patients?

Are Stented Bioprostheses Appropriate for Aortic Valve Replacement in Young Patients? Are Stented Bioprostheses Appropriate for Aortic Valve Replacement in Young Patients? Frank A. Pigula MD Senior Associate Cardiac Surgery Children s Hospital Boston Associate Professor Surgery Harvard

More information

My Choice For Percutaneous Mitral Valve Replacement. Jose Luis Navia, MD.

My Choice For Percutaneous Mitral Valve Replacement. Jose Luis Navia, MD. My Choice For Percutaneous Mitral Valve Replacement Jose Luis Navia, MD. Disclosure Edwards Lifescienses St. Jude Medical MAQUET NaviGate Consultant, Investigator Consultant, Investigator Consultant, Investigator

More information

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,

More information

Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment

Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment W.R.E. Jamieson, MD; L.H. Burr, MD; R.T. Miyagishima, MD; M.T. Janusz, MD; G.J. Fradet, MD; S.V. Lichtenstein, MD; H. Ling, MD Background

More information

Aortic valve repair is an accepted option for aortic valve

Aortic valve repair is an accepted option for aortic valve Complex Aortic Valve Disease in Children Christopher W. Baird, MD,* and Pedro J. del Nido, MD Aortic valve repair is an accepted option for aortic valve pathologic conditions in children and young adults.

More information

Quantitative Histological Examination of Bioprosthetic Heart Valves

Quantitative Histological Examination of Bioprosthetic Heart Valves MAJOR ARTICLE Quantitative Histological Examination of Bioprosthetic Heart Valves Hubert Lepidi, 1 Jean-Paul Casalta, 1 Pierre-Edouard Fournier, 1 Gilbert Habib, 2 Frédéric Collart, 3 and Didier Raoult

More information

of the Right Ventricular Outflow Tract

of the Right Ventricular Outflow Tract Late Results of Reconstruction of the Right Ventricular Outflow Tract with Porcine Xenogafts in Children George S. Bisset 111, M.D., David C. Schwartz, M.D., George Benzing 111, M.D., James Helmsworth,

More information

The Edge-to-Edge Technique f For Barlow's Disease

The Edge-to-Edge Technique f For Barlow's Disease The Edge-to-Edge Technique f For Barlow's Disease Ottavio Alfieri, Michele De Bonis, Elisabetta Lapenna, Francesco Maisano, Lucia Torracca, Giovanni La Canna. Department of Cardiac Surgery, San Raffaele

More information

Aortic root enlargement is an invaluable surgical technique

Aortic root enlargement is an invaluable surgical technique Aortic Root Enlargement in the Adult Christopher M. Feindel, MD, CM, FRCS(C) Aortic root enlargement is an invaluable surgical technique with which every cardiac surgeon performing aortic valve replacement

More information

The stentless bioprosthesis has many salient features that

The stentless bioprosthesis has many salient features that Aortic Valve Replacement with the Medtronic Freestyle Xenograft Using the Subcoronary Implantation Technique D. Michael Deeb, MD The stentless bioprosthesis has many salient features that make it an attractive

More information

Repair or Replacement

Repair or Replacement Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division

More information

Comparison of Viable and Betapropiolactone-Treated Orthotopic Homologous Aortic Valves in Dogs

Comparison of Viable and Betapropiolactone-Treated Orthotopic Homologous Aortic Valves in Dogs THE ANNALS OF THORACIC SURGERY Journal of The Society of Thoracic Surgeons and the Southern Thoracic Surgical Association VOLUME 13 NUMBER 3 * MARCH 1972 Comparison of Viable and Betapropiolactone-Treated

More information

The clinical experience reported in recent Western series has provided

The clinical experience reported in recent Western series has provided Surgery for Acquired Cardiovascular Disease Yu et al Long-term evaluation of Carpentier-Edwards porcine bioprosthesis for rheumatic heart disease Hsi-Yu Yu, MD a Yi-Lwun Ho, MD b Shu-Hsun Chu, MD c Yih-Sharng

More information

Case. 15-year-old boy with bicuspid AV Severe AR with moderate AS. Ross vs. AVR (or AVP)

Case. 15-year-old boy with bicuspid AV Severe AR with moderate AS. Ross vs. AVR (or AVP) Case 15-year-old boy with bicuspid AV Severe AR with moderate AS Ross vs. AVR (or AVP) AMC case 14-year-old boy with bicuspid AV Severe AS with mild AR Body size Bwt: 55 kg, Ht: 154 cm, BSA: 1.53 m 2 Echocardiography

More information

Degeneration of porcine bioprosthetic valves

Degeneration of porcine bioprosthetic valves Vibrational Analysis of Bioprosthetic Heart Valve Leaflets Using Numerical Models: Effects of Leaflet Stiffening, Calcification, and Perforation 687 Mohamed S. Hamid, Hani N. Sabbah, and Paul D. Stein

More information

Carpentier-Edwards supra-annular aortic porcine bioprosthesis: Clinical performance over 20 years

Carpentier-Edwards supra-annular aortic porcine bioprosthesis: Clinical performance over 20 years Surgery for Acquired Cardiovascular Disease Carpentier-Edwards supra-annular aortic porcine bioprosthesis: Clinical performance over 20 years W. R. Eric Jamieson, MD, Lawrence H. Burr, MD, Robert T. Miyagishima,

More information

The clinical problem of atrioventricular valve regurgitation

The clinical problem of atrioventricular valve regurgitation Mitral Regurgitation in Congenital Heart Defects: Surgical Techniques for Reconstruction Richard G. Ohye Mitral valve regurgitation (MR) is an important source of morbidity and mortality worldwide. While

More information

Medtronic Mosaic porcine bioprosthesis: Assessment of 12-year performance

Medtronic Mosaic porcine bioprosthesis: Assessment of 12-year performance Medtronic Mosaic porcine bioprosthesis: Assessment of 12-year performance W. R. Eric Jamieson, MD, a Friedrich-Christian Riess, MD, b Peter J. Raudkivi, MD, c Jacques Metras, MD, d Edward F. G. Busse,

More information

ICE: Echo Core Lab-CRF

ICE: Echo Core Lab-CRF APPENDIX 1 ICE: Echo Core Lab-CRF Study #: - Pt Initials: 1. Date of study: / / D D M M M Y Y Y Y 2. Type of Study: TTE TEE 3. Quality of Study: Poor Moderate Excellent Ejection Fraction 4. Ejection Fraction

More information

Incidence of prosthesis-patient mismatch in patients receiving mitral Biocor porcine prosthetic valves

Incidence of prosthesis-patient mismatch in patients receiving mitral Biocor porcine prosthetic valves INTERVENTION/VALVULAR HEART DISEASE ORIGINAL ARTICLE Cardiology Journal 2016, Vol. 23, No. 2, 178 183 DOI: 10.5603/CJ.a2016.0011 Copyright 2016 Via Medica ISSN 1897 5593 Incidence of prosthesis-patient

More information

A tions in the United States annually [l]. Despite. Calcification of Porcine Valves: A Successful New Method of Antimineralization

A tions in the United States annually [l]. Despite. Calcification of Porcine Valves: A Successful New Method of Antimineralization Calcification of Porcine Valves: A Successful New Method of Antimineralization John Parker Gott, MD, Pan-Chih, MD, Lynne M. A. Dorsey, MBA, John L. Jay, MD, G. Kimble Jett, MD, Frederick J. Schoen, MD,

More information

Hemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves

Hemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves Hemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves Speaker's name: I have the following potential conflicts of interest to report: Proctorship for Medtronic Agenda Failure modes

More information

Doppler-Echocardiographic Assessment of Carbomedics Prosthetic Valves in the Mitral Position

Doppler-Echocardiographic Assessment of Carbomedics Prosthetic Valves in the Mitral Position Doppler-Echocardiographic Assessment of Carbomedics Prosthetic Valves in the Mitral Position Chee-Siong Soo, MRCP, Mestres Ca, MD, Monica Tay, Joon-Kuan Yeoh, MRCP, Eugene Sim, FRCS, and M. Choo, FRCP,

More information

Anatomy of left ventricular outflow tract'

Anatomy of left ventricular outflow tract' Anatomy of left ventricular outflow tract' ROBERT WALMSLEY British Heart Journal, 1979, 41, 263-267 From the Department of Anatomy and Experimental Pathology, The University, St Andrews, Scotland SUMMARY

More information

RESEARCH AND REVIEWS: JOURNAL OF PHARMACOLOGY AND TOXICOLOGICAL STUDIES

RESEARCH AND REVIEWS: JOURNAL OF PHARMACOLOGY AND TOXICOLOGICAL STUDIES e-issn:2322-0139 RESEARCH AND REVIEWS: JOURNAL OF PHARMACOLOGY AND TOXICOLOGICAL STUDIES Comparative Evaluation of Safety Outcomes of Different Prosthetic Valves in Indian Subjects. Kama Raval 1 *, Reena

More information

Management of Difficult Aortic Root, Old and New solutions

Management of Difficult Aortic Root, Old and New solutions Management of Difficult Aortic Root, Old and New solutions Hani K. Najm MD, Msc, FRCSC,, FACC, FESC Chairman, Pediatric and Congenital Heart Surgery Cleveland Clinic Conflict of Interest None Difficult

More information

Department of Cardiothoracic Surgery, Heart and Lung Center, Lund University Hospital, Lund, Sweden

Department of Cardiothoracic Surgery, Heart and Lung Center, Lund University Hospital, Lund, Sweden Long-Term Outcome of the Mitroflow Pericardial Bioprosthesis in the Elderly after Aortic Valve Replacement Johan Sjögren, Tomas Gudbjartsson, Lars I. Thulin Department of Cardiothoracic Surgery, Heart

More information

Techniques for repair of complete atrioventricular septal

Techniques for repair of complete atrioventricular septal No Ventricular Septal Defect Patch Atrioventricular Septal Defect Repair Carl L. Backer, MD *, Osama Eltayeb, MD *, Michael C. Mongé, MD *, and John M. Costello, MD For the past 10 years, our center has

More information

By the end of this session, the student should be able to:

By the end of this session, the student should be able to: Valvular Heart disease HVD By Dr. Ashraf Abdelfatah Deyab VHD- Objectives By the end of this session, the student should be able to: Define and classify valvular heart disease. Enlist the causes of acquired

More information

The CarboMedics bileaflet prosthetic heart was introduced

The CarboMedics bileaflet prosthetic heart was introduced The CarboMedics Valve: Experience With 1,049 Implants José M. Bernal, MD, José M. Rabasa, MD, Francisco Gutierrez-Garcia, MD, Carlos Morales, MD, J. Francisco Nistal, MD, and José M. Revuelta, MD Department

More information

The growing sheep model has been used extensively

The growing sheep model has been used extensively Behavior of Mitral Allografts in the Tricuspid Position in the Growing Sheep Model José M. Bernal, MD, José M. Rabasa, MD, Juan C. Cagigas, MD, Fernando Val, MD, and José M. Revuelta, MD Departments of

More information

A prospective evaluation of the Bjbrk-Shiley, Hancock, and Carpentier-Edwards heart valve prostheses

A prospective evaluation of the Bjbrk-Shiley, Hancock, and Carpentier-Edwards heart valve prostheses THERAPY AND PREVENTION VALVE REPLACEMENT A prospective evaluation of the Bjbrk-Shiley, Hancock, and Carpentier-Edwards heart valve prostheses PETER BLOOMFIELD, M.R.C.P., ARTHUR H. KITCHIN, F.R.C.P.. DAVID

More information

Tricuspid Valve Repair for Ebstein's Anomaly

Tricuspid Valve Repair for Ebstein's Anomaly Tricuspid Valve Repair for Ebstein's Anomaly Joseph A. Dearani, MD, and Gordon K. Danielson, MD E bstein's anomaly is a malformation of the tricuspid valve and right ventricle that is characterized by

More information

Calcification Resistance With Aluminum-Ethanol Treated Porcine Aortic Valve Bioprostheses in Juvenile Sheep

Calcification Resistance With Aluminum-Ethanol Treated Porcine Aortic Valve Bioprostheses in Juvenile Sheep Calcification Resistance With Aluminum-Ethanol Treated Porcine Aortic Valve Bioprostheses in Juvenile Sheep Matthew F. Ogle, MS, Sheila J. Kelly, BS, Richard W. Bianco, BS, and Robert J. Levy, MD Heart

More information